BICO Group AB
BICO Group AB is a provider of advanced medical equipment and technology, specializing in the development and commercialization of innovative solutions for the healthcare industry.
Business. BICO Group AB (BICO.ST) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on product sales. Headquartered in Sweden, the company is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
Analyst recommendations
3 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BICO Group AB (BICO.ST) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on product sales. Headquartered in Sweden, the company is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
BICO Group AB has a liquidity position that is currently medium, with a current ratio of 2.86, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -50.2 million SEK, and operating cash flow is also negative at -68.2 million SEK, suggesting cash generation is a challenge. The company holds 687.6 million SEK in cash and equivalents, but this is offset by long-term debt of 1.957 billion SEK, resulting in a debt-to-equity ratio of 0.66.
Profitability metrics for BICO Group AB are weak, with a return on equity of -2.64% and a return on assets of -1.37%. These figures are below the industry median for the Advanced Medical Equipment & Technology sector, indicating underperformance in generating returns for shareholders and asset utilization. The company reported a net loss of 77.8 million SEK and an operating loss of 49.6 million SEK, further highlighting the challenges in achieving profitability.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue data limits the ability to assess the performance of different product lines or geographic regions.
Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of improvement in the next fiscal year. The negative operating and net income, combined with the lack of positive cash flow, suggests the company is not currently in a position to sustain growth without external financing or operational improvements.
Risk factors for BICO Group AB include liquidity constraints and the potential for dilution, although the latter is currently assessed as low. The company's net cash position is negative after accounting for total debt, which could limit its ability to invest in growth opportunities or weather economic downturns. The risk assessment also highlights the need for the company to improve its cash flow generation and reduce debt levels to enhance financial stability.
Recent events and disclosures indicate that the company is under pressure to improve its financial performance. Analysts have provided a mean price target of 28.75 SEK, with a median of 27.50 SEK, suggesting a cautious outlook. The mean recommendation of 2.67 (on a scale from 1 to 5) indicates a mixed sentiment, with no strong buy ratings and only one buy rating among the analysts surveyed.
- BICO Group AB is currently unprofitable, with a net loss of 77.8 million SEK and an operating loss of 49.6 million SEK.
- The company's liquidity position is medium, with a current ratio of 2.86, but it faces challenges in generating positive cash flow.
- Return on equity and return on assets are negative, indicating poor performance in generating returns for shareholders and utilizing assets effectively.
- The company's revenue is concentrated in a single segment, increasing exposure to regional and regulatory risks.
- Analysts have a mixed outlook, with a mean price target of 28.75 SEK and a mean recommendation of 2.67.
Bull / Bear case
Generated · model-assistedAnalysts project 114.9% upside to a mean price target of 28.75 SEK, significantly above the current market price of 13.38 SEK.
Return on equity of -2.64% exceeds the cohort median of -4.71%, indicating relatively better capital efficiency among peers.
Cash conversion ratio of 0.88 surpasses the cohort median of 0.79, suggesting superior operational cash generation relative to peers.
Revenue demonstrated a 4.5% compound annual growth rate over the four-year period from 2022 to 2026.
Debt-to-equity ratio of 0.66 places the company in the bottom quartile of its cohort, reflecting high leverage risk.
Revenue declined 13.3% year-over-year to 1.50 billion SEK in FY2026, marking a contraction in top-line growth.
In focus — financials by report
Revenue kr 329.9M, −15,1% YoY; Operating income −43,5% YoY.
- ▍Revenue kr 329.9M, −15,1% YoY
- ▍Operating income −43,5% YoY
- ▍Net income +43,8% YoY
- ▍Free cash flow +62,9% YoY
- ▍Net margin -39.8%
Revenue kr 451.3M, −12,4% YoY; Operating income −213,2% YoY.
- ▍Revenue kr 451.3M, −12,4% YoY
- ▍Operating income −213,2% YoY
- ▍Net income −117,1% YoY
- ▍Free cash flow −97,3% YoY
- ▍Net margin -13.1%
Revenue kr 386.9M, +4,8% YoY; Operating income −1 584,8% YoY.
- ▍Revenue kr 386.9M, +4,8% YoY
- ▍Operating income −1 584,8% YoY
- ▍Net income −148,5% YoY
- ▍Free cash flow −394,0% YoY
- ▍Net margin -158.1%
Revenue kr 324.2M, −23,4% YoY; Operating income −112,5% YoY.
- ▍Revenue kr 324.2M, −23,4% YoY
- ▍Operating income −112,5% YoY
- ▍Net income −136,8% YoY
- ▍Free cash flow −151,4% YoY
- ▍Net margin -56.8%
Revenue kr 388.6M; Operating income -kr 79.1M.
- ▍Revenue kr 388.6M
- ▍Operating income -kr 79.1M
- ▍Net margin -60.2%
Revenue kr 515.1M; Operating income -kr 8.3M.
- ▍Revenue kr 515.1M
- ▍Operating income -kr 8.3M
- ▍Net margin 67.3%
Revenue kr 369.1M; Operating income -kr 64.3M.
- ▍Revenue kr 369.1M
- ▍Operating income -kr 64.3M
- ▍Net margin -66.7%
Revenue kr 423.3M; Operating income -kr 49.6M.
- ▍Revenue kr 423.3M
- ▍Operating income -kr 49.6M
- ▍Net margin -18.4%
Revenue kr 1.50B, −13,3% YoY; Operating income −341,8% YoY.
- ▍Revenue kr 1.50B, −13,3% YoY
- ▍Operating income −341,8% YoY
- ▍Net income −20 445,3% YoY
- ▍Free cash flow −911,0% YoY
- ▍Net margin -72.7%
Revenue kr 1.73B, −14,1% YoY; Operating income +49,2% YoY.
- ▍Revenue kr 1.73B, −14,1% YoY
- ▍Operating income +49,2% YoY
- ▍Net income +99,5% YoY
- ▍Free cash flow +125,7% YoY
- ▍Net margin -0.3%
Revenue kr 2.01B, −5,2% YoY; Operating income −106,2% YoY.
- ▍Revenue kr 2.01B, −5,2% YoY
- ▍Operating income −106,2% YoY
- ▍Net income −40,8% YoY
- ▍Free cash flow −115,8% YoY
- ▍Net margin -58.3%
Revenue kr 2.12B, +68,7% YoY; Operating income −16,0% YoY.
- ▍Revenue kr 2.12B, +68,7% YoY
- ▍Operating income −16,0% YoY
- ▍Net income −265,9% YoY
- ▍Free cash flow −0,7% YoY
- ▍Net margin -39.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -1,64 |
| Revenue | —no estimate | —no estimate | 1,6B SEK |
| Operating income | —no estimate | —no estimate | -134,7M SEK |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- BICO Group AB Market data — financials · 2026-05-27
- BICO Group AB Market data — analyst estimates · 2026-05-27
- BICO Group AB Market data — ESG · 2026-05-27
Ownership & reference
Leadership
- Maria ForssPresident, Chief Executive Officer